Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lane Labs To Pay Consumer Restitution Under Permanent Injunction

This article was originally published in The Tan Sheet

Executive Summary

The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9
Advertisement

Related Content

Lane Labs Violates Injunction With Unsubstantiated Fertil Male Claims – FTC
Lane Labs Violates Injunction With Unsubstantiated Fertil Male Claims – FTC
Lane Labs Violates Injunction With Unsubstantiated Fertil Male Claims – FTC
Lane Labs
Lane Labs
Lane Labs Takes FD&C Act Challenge To Appellate Court
Lane Lawyers Plan To Challenge FDA Restitution Power Under FD&C Act
Lane Labs FTC Settlement To Fund National Cancer Institute Study
Lane Labs BeneFin Is Unapproved Drug - FDA Complaint
Lane Labs BeneFin Is Unapproved Drug - FDA Complaint

Topics

Advertisement
UsernamePublicRestriction

Register

PS097069

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel